WallStreetZenWallStreetZen

AnalystsChristopher Raymond
Christopher Raymond's Stock Forecasts

Analyst Ranking
Top 25%
#1023 out of 4125 analysts
Average Return
+2.21%
Win Rate
53%21 out of 40
Risk vs Reward
Poor
Good

Christopher Raymond's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Inovio Pharmaceuticals IncINO
+196.98%$2.98$8.85
2020-01-03 -
2020-12-31
Strong Buy
Allovir IncALVR
+91.41%$3.96$7.58
2022-05-19 -
2022-12-01
Strong Buy
Prevail Therapeutics IncPRVL
+64.64%$13.97$23.00
2020-04-09 -
2021-01-21
Strong Buy
Alx Oncology Holdings IncALXO
+59.19%$41.02$65.30
2020-08-11 -
2021-08-09
Strong Buy
Biohaven LtdBHVN
+49.05%$11.09$16.53
2022-10-12 -
2022-12-01
Strong Buy

Christopher Raymond's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Ardelyx IncARDX
3Strong Buy$8.00+357.14%Upgrades
15 days ago
Amgen IncAMGN
6Strong Buy$278.00-2.78%Maintains
a month ago
Regeneron Pharmaceuticals IncREGN
2Strong Buy$765.00+0.49%Maintains
a month ago
Biohaven LtdBHVN
2Strong Buy$21.00+27.04%Maintains
a month ago
Otonomy IncOTIC
1Hold$0.50+206.75%Downgrades
2 months ago
Biogen IncBIIB
5Hold$280.00-7.24%Maintains
2 months ago
Biohaven Pharmaceutical Holding Co LtdBHVN1
2HoldN/AN/ADowngrades
3 months ago
Aptinyx IncAPTX
3Hold$2.00+635.29%Downgrades
4 months ago
Biomarin Pharmaceutical IncBMRN
3Strong Buy$128.00+24.25%Maintains
4 months ago
Ultragenyx Pharmaceutical IncRARE
3Strong Buy$130.00+243.82%Maintains
4 months ago
Vectivbio Holding AgVECT
1Strong Buy$23.00+178.79%Initiates Coverage On
5 months ago
Oncorus IncONCR
2Strong Buy$12.00+2,566.67%Maintains
6 months ago
Kinnate Biopharma IncKNTE
1Strong Buy$30.00+287.10%Maintains
6 months ago
Graybug Vision IncGRAY
4Hold$2.00+217.46%Maintains
6 months ago
Blueprint Medicines CorpBPMC
1Hold$65.00+36.87%Maintains
6 months ago
Alx Oncology Holdings IncALXO
2Strong Buy$48.00+333.21%Maintains
6 months ago
Allovir IncALVR
1Strong Buy$34.00+348.55%Maintains
6 months ago
Acceleron Pharma IncXLRN
2Hold$180.00N/ADowngrades
a year ago
Nuvalent IncNUVL
1Strong Buy$40.00N/AInitiates Coverage On
a year ago
Solid Biosciences IncSLDB
1Hold$6.00N/AInitiates Coverage On
a year ago
Aclaris Therapeutics IncACRS
1Strong Buy$30.00N/AInitiates Coverage On
a year ago
Amag Pharmaceuticals IncAMAG
2HoldN/AN/AUpgrades
2 years ago
Aimmune Therapeutics IncAIMT
1Hold$34.50N/ADowngrades
2 years ago
Prevail Therapeutics IncPRVL
1Strong Buy$20.00N/AInitiates Coverage On
3 years ago
Inovio Pharmaceuticals IncINO
2Hold$8.00N/ADowngrades
3 years ago
Vertex Pharmaceuticals IncVRTX
3HoldN/AN/ADowngrades
4 years ago
Akebia Therapeutics IncAKBA
1Strong Buy$26.00N/AInitiates Coverage On
5 years ago
Alexion Pharmaceuticals IncALXN
1Strong Buy$170.00N/AAssumes
5 years ago
Celgene CorpCELG
1Hold$133.00N/AAssumes
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.